Global Hepatitis B Vaccines Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2017 to 2025

  • ID: 4431766
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • CSL Limited
  • Dynavax Technologies
  • Emergent Biosolutions
  • Merck & Co, Inc.
  • Novartis AG
  • Pfizer Inc.
  • MORE
Hepatitis B Vaccines Market - Growth, Future Prospects and Competitive Analysis, 2017 - 2025 the global hepatitis B vaccines market was valued at US$ 1.39 Bn in 2016, and is expected to reach US$ 1.89 Bn by 2025, expanding at a CAGR of 3.5% from 2017 to 2025.

Market Insights

Hepatitis B is life threatening liver infection. Hepatitis B vaccines market is rapidly growing as it is effective in prevention of infection than any other treatment options. Some factors such as increased awareness of hepatitis B infection prevention, government initiatives in conduction of routine immunization program are contributing the market growth of hepatitis B vaccines globally. For the purpose of study, global hepatitis B vaccines market is segmented on the basis of type of vaccines composition such as mono and combination vaccines. It is observed that in the base year 2016, combination vaccines held largest market share due to factors such as more patient compliance, better disease control and lower chances of missing immunization are driving the growth of combination vaccines market globally. On the basis of end users age, the hepatitis B vaccines market is categorized into pediatric and adult hepatitis B vaccines. Currently, adult hepatitis B vaccines is the major revenue contributing segment as adults are at a high risk of developing hepatitis B infections due to renal disease and HIV infection which is influencing the market growth of adult hepatitis B vaccines globally. Hepatitis B vaccines market is currently dominated by North America due to factors such as extensive R&D activities, higher cost of vaccines and immunization program that are driving the market growth in North America. Asia Pacific is anticipated to show highest CAGR during forecast period due to increasing healthcare awareness and government initiatives in immunization program.

Market Competition Assessment

The hepatitis B vaccines market is observed to be highly competitive and comprises large number of players. However, the market is currently dominated by few players such as Beijing Minhai Biotechnology, CSL Ltd, Dynavax Technologies, Emergent Biosolutions, GlaxoSmithKline Biologicals, Merck & Co, Inc, Novartis AG, Pfizer Inc., Sanofi Pasteur, Serum Institute of India, Sinovac Biotech and other.

Key Market Movements:
  • Governments across the world have mandated the immunization of hepatitis B for travelers. Hepatitis B vaccine is included in government national immunization schedules in various countries. And increase in awareness of hepatitis B infection prevention is driving the growth of hepatitis B vaccines market worldwide.
  • Processes of vaccine development and approval is stringently regulated by the regulatory authorities, which may negatively impact the market growth of hepatitis B vaccines globally.
  • Hepatitis B vaccine requires cold storage condition, it increases the market price of vaccines. This would hinder the market growth in some countries.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • CSL Limited
  • Dynavax Technologies
  • Emergent Biosolutions
  • Merck & Co, Inc.
  • Novartis AG
  • Pfizer Inc.
  • MORE
Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I - Secondary Research
1.3.2 Phase II - Primary Research
1.3.3 Phase III - Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Hepatitis B Vaccines Market Snapshot
2.2 Global Hepatitis B Vaccines Market, by Composition, 2016 (US$ Bn)
2.3 Global Hepatitis B Vaccines Market, by End Users Age, 2016 (US$ Bn)
2.4 Global Hepatitis B Vaccines Market Share, by Geography, 2016 (Value %)

Chapter 3 Hepatitis B Vaccines Market Analysis
3.1 Global Hepatitis B Vaccines Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.1.1 Government initiative in Hepatitis B vaccine Immunization
3.2.2 Challenges
3.2.2.1 Stringent Regulatory Guidelines
3.2.3 Opportunities
3.2.3.1 Increase in Awareness of Hepatitis B Infection and Prevention
3.3 Attractive Investment Proposition
3.4 Competitive Landscape of Key Players in Hepatitis B Vaccines Market

Chapter 4 Global Hepatitis B Vaccines Market, by Composition
4.1 Overview
4.2 Combination Vaccines
4.3 Mono Vaccines

Chapter 5 Global Hepatitis B Vaccines Market, by End Users Age
5.1 Overview
5.2 Adult Hepatitis B vaccines
5.3 Paediatric Hepatitis B vaccines

Chapter 6 Global Hepatitis B Vaccines Market, By Geography
6.1 Preface
6.2 North America (U.S. & Canada)
6.3 Europe (U.K., Germany & Rest of Europe)
6.4 Asia Pacific (China, Japan and Rest of APAC)
6.5 Latin America
6.6 Middle East and Africa

Chapter 7 Company Profiles
7.1 Beijing Minhai Biotechnology
7.2 CSL Limited
7.3 Dynavax Technologies
7.4 Emergent Biosolutions
7.5 GlaxoSmithKline Biologicals
7.6 Merck & Co, Inc.
7.7 Novartis AG
7.8 Pfizer Inc.
7.9 Sanofi Pasteur
7.10 Serum Institute of India
7.11 Sinovac Biotech

List of Figures
Fig. 1 Hepatitis B Vaccines Market: Research Methodology
Fig. 2 Global Hepatitis B Vaccines Market, by Composition, 2016 (US$ Bn)
Fig. 3 Global Hepatitis B Vaccines Market, by End Users Age, 2016 (US$ Bn)
Fig. 4 Global Hepatitis B Vaccines Market Share, by Geography, 2016 (Value %)
Fig. 5 Attractive Investment Proposition: Global Hepatitis B Vaccines Market, by Geography, 2016
Fig. 6 Global Combination Vaccines Market for Hepatitis B Vaccines, 2015 - 2025 (US$ Bn)
Fig. 7 Global Mono Vaccines Market for Hepatitis B Vaccines, 2015 - 2025 (US$ Bn)
Fig. 8 Global Hepatitis B Vaccines Market for Adult Hepatitis B, 2015 - 2025 (US$ Bn)
Fig. 9 Global Hepatitis B Vaccines Market for Paediatric Hepatitis B, 2015 - 2025 (US$ Bn)
Fig. 10 Latin America Hepatitis B Vaccines Market, 2015 - 2025 (US$ Bn)
Fig. 11 Middle East and Africa Hepatitis B Vaccines Market, 2015 - 2025 (US$ Bn)

List of Tables
Table 1 Market Positioning of Key Players in Global Hepatitis B Vaccines Market
Table 2 Global Hepatitis B Vaccines Market, by Composition, 2015 - 2025 (US$ Bn)
Table 3 Global Hepatitis B Vaccines Market, by End Users Age, 2015 - 2025 (US$ Bn)
Table 4 Global Hepatitis B Vaccines Market, by Geography, 2015 - 2025 (US$ Bn)
Table 5 North America Hepatitis B Vaccines Market, by Country, 2015 - 2025 (US$ Bn)
Table 6 Europe Hepatitis B Vaccines Market, by Country, 2015 - 2025 (US$ Bn)
Table 7 Asia Pacific Hepatitis B Vaccines Market, by Country, 2015 - 2025 (US$ Bn)
Table 8 Beijing Minhai Biotechnology: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 9 CSL Limited: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 10 Dynavax Technologies: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 11 Emergent Biosolutions: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 12 GlaxoSmithKline Biologicals: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 13 Merck & Co, Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 14 Novartis AG: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 15 Pfizer Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 16 Sanofi Pasteur: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 17 Serum Institute of India: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Table 18 Sinovac Biotech: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Beijing Minhai Biotechnology
  • CSL Limited
  • Dynavax Technologies
  • Emergent Biosolutions
  • GlaxoSmithKline Biologicals
  • Merck & Co, Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi Pasteur
  • Serum Institute of India
  • Sinovac Biotech
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll